Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 5/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tonabersat SCHEMBL7790566 | 0.82 | ABCC9 (0.46) | ABCC9 | |
| SCHEMBL15546692 | 0.77 | ABCC9 (0.48) | ABCC9 | |
| SCHEMBL15546693 | 0.77 | ABCC9 (0.48) | ABCC9 | |
| SCHEMBL16863527 | 0.73 | ABCC9 (0.47) | ABCC9 | |
| SCHEMBL16863528 | 0.73 | ABCC9 (0.47) | ABCC9 | |
| SCHEMBL15546301 | 0.73 | ABCC9 (0.47) | ABCC9 | |
| SCHEMBL15546299 | 0.73 | ABCC9 (0.47) | ABCC9 | |
| SCHEMBL16862878 | 0.73 | ABCC9 (0.45) | ABCC9 | |
| SCHEMBL16862881 | 0.73 | ABCC9 (0.45) | ABCC9 | |
| SCHEMBL15546601 | 0.73 | ABCC9 (0.45) | ABCC9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010027248-A1 | Novel receptor | SMITHKLINE BEECHAM P.L.C. | 2001-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010027248-A1 | Novel receptor | ADGRF1, TACR2, GPR4 | ABCC9 2047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.